Skip to main content
Premium Trial:

Request an Annual Quote

Lexogen Nabs Austrian Funding for RNA-Seq Coronavirus Test

NEW YORK – Lexogen announced Wednesday it has received funding from the Austrian government to develop an RNA sequencing-based COVID-19 diagnostic test for mass screening.

The funding was part of a €16 million ($17.4 million) disbursement from the Austria Research Promotion Agency to companies pursuing vaccines, therapeutics, and diagnostics for COVID-19. A Lexogen spokesperson declined to disclose the exact amount the firm received, but said "the amount granted is exactly what we asked for and it will allow us to develop the test according to the planned timeline, which is very soon given the urgency of having such test for the community."

The Vienna-based sample preparation firm will base its new test on its QuantSeq-Flex Targeted RNA-seq platform. The firm said in a statement the test will allow screening of tens of thousands of samples in parallel.

"Identifying the newly infected on a broad scale will allow us to isolate entire infection clusters at an early stage and help fight the present pandemic as well as reoccurring infection waves," Lexogen CEO and founder Alexander Seitz said in a statement. "It will also enable us to screen hospitals and retirement homes and test especially first responders and front-line workers on a daily basis, helping to keep these essential facilities open and safe."

Lexogen added it will also provide a test for tracking mutations in SARS-CoV-2, the virus that causes COVID-19.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.